Details

---

Manufacturer
NOVARTIS SAGLIK(TURKEY)

Registraction Number
MAL15125062ARZ

Content:
Entresto (sacubitril/valsartan) 100 mg film-coated tablets contain 48.6 mg of sacubitril and 51.4 mg of valsartan (as sacubitril valsartan sodium salt complex).
Indications:

• Heart Failure: Treatment of heart failure with reduced ejection fraction (HFrEF) in adults to reduce the risk of cardiovascular death and hospitalization.
• Hypertension: Treatment of high blood pressure in adults.

Instructions:

1. Dosage: The target dose is 100 mg twice daily. The typical starting dose is 50 mg twice daily, which may be doubled after 2-4 weeks to the target dose.
2. Consistency: Take the tablet at the same time each day.
3. Adherence: Do not miss doses, as this can increase the risk of heart failure.
4. Monitoring: Regular monitoring of blood pressure, kidney function, and electrolytes is recommended.